Home › Apatorsen added to first-line chemotherapy benefits metastatic bladder cancer patients
 

Keywords :   


Apatorsen added to first-line chemotherapy benefits metastatic bladder cancer patients

2015-06-02 17:19:37| Logistics - Topix.net

OncoGenex Pharmaceuticals, Inc. announced that results from an exploratory analysis of the Phase 2 Borealis-1 trial showed that metastatic bladder cancer patients with poor prognostic features benefited from apatorsen 600mg added to first-line chemotherapy compared to chemotherapy alone. Patients in the trial with a Karnofsky Performance Status of 80 percent or less, a common indicator of poor prognosis, experienced a 50 percent reduction in risk of death with the addition of apatorsen therapy .

Tags: added benefits cancer patients

Category:Transportation and Logistics

Latest from this category

All news
15.11Tropical Storm Sara Graphics
15.11Tropical Storm Sara Forecast Discussion Number 6
15.11Tropical Storm Sara Wind Speed Probabilities Number 6
15.11Summary for Tropical Storm Sara (AT4/AL192024)
15.11Tropical Storm Sara Public Advisory Number 6
15.11Tropical Storm Sara Forecast Advisory Number 6
15.11Summary for Tropical Storm Sara (AT4/AL192024)
15.11Tropical Storm Sara Public Advisory Number 5A
Transportation and Logistics »
15.112
15.11
15.11 RIDE THE 92 23-24
15.11
15.114m×4m
15.11FG/AG 25.0
15.11
15.11Edwards
More »